X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE CADILA HEALTHCARE TTK HEALTHCARE/
CADILA HEALTHCARE
 
P/E (TTM) x 29.2 34.3 85.1% View Chart
P/BV x 5.4 8.8 60.8% View Chart
Dividend Yield % 0.5 0.7 78.1%  

Financials

 TTK HEALTHCARE   CADILA HEALTHCARE
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
CADILA HEALTHCARE
Mar-16
TTK HEALTHCARE/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs663454 146.0%   
Low Rs399305 131.0%   
Sales per share (Unadj.) Rs535.696.1 557.4%  
Earnings per share (Unadj.) Rs15.914.9 107.2%  
Cash flow per share (Unadj.) Rs20.017.8 112.3%  
Dividends per share (Unadj.) Rs4.003.20 125.0%  
Dividend yield (eoy) %0.80.8 89.3%  
Book value per share (Unadj.) Rs137.652.3 263.2%  
Shares outstanding (eoy) m7.771,023.74 0.8%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x1.03.9 25.1%   
Avg P/E ratio x33.325.5 130.6%  
P/CF ratio (eoy) x26.521.3 124.6%  
Price / Book Value ratio x3.97.3 53.2%  
Dividend payout %25.121.5 116.6%   
Avg Mkt Cap Rs m4,127388,458 1.1%   
No. of employees `0001.715.4 11.1%   
Total wages/salary Rs m60713,317 4.6%   
Avg. sales/employee Rs Th2,436.76,371.1 38.2%   
Avg. wages/employee Rs Th355.2862.4 41.2%   
Avg. net profit/employee Rs Th72.5986.1 7.4%   
INCOME DATA
Net Sales Rs m4,16298,376 4.2%  
Other income Rs m61941 6.5%   
Total revenues Rs m4,22399,317 4.3%   
Gross profit Rs m19723,829 0.8%  
Depreciation Rs m323,022 1.0%   
Interest Rs m30486 6.2%   
Profit before tax Rs m19721,262 0.9%   
Minority Interest Rs m0-300 0.0%   
Prior Period Items Rs m05 0.0%   
Extraordinary Inc (Exp) Rs m0-25 0.0%   
Tax Rs m735,716 1.3%   
Profit after tax Rs m12415,226 0.8%  
Gross profit margin %4.724.2 19.6%  
Effective tax rate %37.026.9 137.7%   
Net profit margin %3.015.5 19.2%  
BALANCE SHEET DATA
Current assets Rs m1,62944,376 3.7%   
Current liabilities Rs m1,05834,071 3.1%   
Net working cap to sales %13.710.5 131.0%  
Current ratio x1.51.3 118.2%  
Inventory Days Days3054 55.3%  
Debtors Days Days3462 53.9%  
Net fixed assets Rs m55647,896 1.2%   
Share capital Rs m781,024 7.6%   
"Free" reserves Rs m87848,746 1.8%   
Net worth Rs m1,06953,519 2.0%   
Long term debt Rs m1598,964 1.8%   
Total assets Rs m2,399100,163 2.4%  
Interest coverage x7.644.7 16.9%   
Debt to equity ratio x0.10.2 88.6%  
Sales to assets ratio x1.71.0 176.6%   
Return on assets %6.415.7 40.9%  
Return on equity %11.628.4 40.7%  
Return on capital %18.534.3 53.8%  
Exports to sales %0.845.3 1.7%   
Imports to sales %1.45.9 23.6%   
Exports (fob) Rs m3344,537 0.1%   
Imports (cif) Rs m585,838 1.0%   
Fx inflow Rs m3344,881 0.1%   
Fx outflow Rs m639,069 0.7%   
Net fx Rs m-3035,812 -0.1%   
CASH FLOW
From Operations Rs m12719,938 0.6%  
From Investments Rs m-146-9,039 1.6%  
From Financial Activity Rs m22-9,527 -0.2%  
Net Cashflow Rs m31,372 0.2%  

Share Holding

Indian Promoters % 65.4 74.8 87.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 8.3 44.6%  
FIIs % 5.2 5.9 88.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 11.0 234.5%  
Shareholders   12,723 44,069 28.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  ELDER PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare TTK HEALTHCARE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 23, 2017 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ABBOTT INDIA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS